{
    "title": "Pharma giant AstraZeneca to halt development of a treatment for Crohn's disease",
    "url": "https://www.dailymail.co.uk/money/markets/article-12149629/Astra-blames-delays-ditching-bowel-disease-drug-treatment.html",
    "date": "2023-06-01",
    "keywords": [
        "cancer",
        "drug",
        "share",
        "account",
        "fund",
        "pharma",
        "giant",
        "development",
        "treatment",
        "crohns",
        "disease",
        "ftse",
        "group",
        "brazikumab",
        "bowel",
        "cent",
        "capital",
        "risk",
        "money",
        "investment",
        "fee",
        "astrazeneca",
        "colitiscrohns",
        "tract",
        "pain",
        "fatigue",
        "malnutrition",
        "programme",
        "blaming",
        "timeline",
        "context",
        "landscape",
        "diseasesdespite",
        "broker",
        "shore",
        "decision",
        "approval",
        "prostate",
        "trial",
        "therapy",
        "abiraterone",
        "prednisolone",
        "progression",
        "death",
        "britain",
        "drugmaker",
        "boss",
        "soriot",
        "wire",
        "act",
        "time",
        "article",
        "diy",
        "eu",
        "skin",
        "uk",
        "lifetime",
        "year",
        "die",
        "itlynparza",
        "tube",
        "breast",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}